These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17009783)

  • 1. [Actions and resistance mechanisms of beta-lactam antibiotics. Penicillin-binding proteins, beta-3-lactamases and signal proteins].
    Heisig P
    Pharm Unserer Zeit; 2006; 35(5):400-8. PubMed ID: 17009783
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
    Buynak JD
    Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-lactam resistance: The role of low molecular weight penicillin binding proteins, β-lactamases and ld-transpeptidases in bacteria associated with respiratory tract infections.
    Ealand CS; Machowski EE; Kana BD
    IUBMB Life; 2018 Sep; 70(9):855-868. PubMed ID: 29717815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Penicillin-Binding Protein PbpP Is a Sensor of β-Lactams and Is Required for Activation of the Extracytoplasmic Function σ Factor σ
    Nauta KM; Ho TD; Ellermeier CD
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams.
    Mondon M; Hur S; Vadlamani G; Rodrigues P; Tsybina P; Oliver A; Mark BL; Vocadlo DJ; Blériot Y
    Chem Commun (Camb); 2013 Dec; 49(93):10983-5. PubMed ID: 24136176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic-membrane anchoring of a class A beta-lactamase and its capacity in manifesting antibiotic resistance.
    Suvorov M; Vakulenko SB; Mobashery S
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2937-42. PubMed ID: 17502412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-Binding Proteins, β-Lactamases, and β-Lactamase Inhibitors in β-Lactam-Producing Actinobacteria: Self-Resistance Mechanisms.
    Martin JF; Alvarez-Alvarez R; Liras P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in β-lactam based β-lactamases inhibitors.
    Biondi S; Long S; Panunzio M; Qin WL
    Curr Med Chem; 2011; 18(27):4223-36. PubMed ID: 21838683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
    Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
    Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The streptococcolytic enzyme zoocin A is a penicillin-binding protein.
    Heath LS; Heath HE; LeBlanc PA; Smithberg SR; Dufour M; Simmonds RS; Sloan GL
    FEMS Microbiol Lett; 2004 Jul; 236(2):205-11. PubMed ID: 15251198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M; Hujer AM; Bonomo RA
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.
    Papp-Wallace KM; Senkfor B; Gatta J; Chai W; Taracila MA; Shanmugasundaram V; Han S; Zaniewski RP; Lacey BM; Tomaras AP; Skalweit MJ; Harris ME; Rice LB; Buynak JD; Bonomo RA
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5687-92. PubMed ID: 22908165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Lactamases: A Focus on Current Challenges.
    Bonomo RA
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single report of β-lactam resistance in an invasive Haemophilus influenzae isolate from South Africa mediated by mutations in penicillin-binding protein 3, 2003-2008.
    Fali A; du Plessis M; Wolter N; Klugman KP; von Gottberg A
    Int J Antimicrob Agents; 2010 Nov; 36(5):480-2. PubMed ID: 20846827
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of two-component regulatory system in β-lactam antibiotics resistance.
    Lingzhi L; Haojie G; Dan G; Hongmei M; Yang L; Mengdie J; Chengkun Z; Xiaohui Z
    Microbiol Res; 2018 Oct; 215():126-129. PubMed ID: 30172298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam resistance in anaerobic bacteria: a review.
    Hedberg M; Nord CE
    J Chemother; 1996 Feb; 8(1):3-16. PubMed ID: 8835102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure.
    Ropy A; Cabot G; Sánchez-Diener I; Aguilera C; Moya B; Ayala JA; Oliver A
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3925-34. PubMed ID: 25896695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.